Integrated Rail & Resources Secures $944K in Preferred Stock Deal
Integrated Rail & Resources Inc. announces a $944,400 financing deal with Huntington Oil & Gas III, LLC to enhance operational capabilities.
PUBLIC CO MANAGEMENT CORP Establishes New Series of Preferred Stock
PUBLIC CO MANAGEMENT CORP has filed to establish three new series of Preferred Stock, altering its capital structure and voting dynamics.
Arbutus Biopharma Gains FDA Clearance for AB-101 Trials
Arbutus Biopharma announced FDA lifted clinical hold on AB-101, its oral PD-L1 inhibitor, allowing further trials. This could impact the hepatitis B treatment landscape.
K&F Growth Acquisition Corp. II Enters New Agreement with David's Bridal
K&F Growth Acquisition Corp. II announces a new agreement with David's Bridal, marking a potential business combination in the wedding industry.
Permian Basin Royalty Trust Calls Special Meeting for Unit Holders
Permian Basin Royalty Trust announces a special meeting for unit holders to vote on significant proposals, impacting its future and governance.
GSK secures FDA approval for Ionis' HIBSAGO™ for hepatitis B
Ionis Pharmaceuticals' partner GSK receives FDA approval for HIBSAGO™, a groundbreaking treatment for chronic hepatitis B, enhancing patient care.
Navient Corp Announces Tax-Free Merger to Form New Holding Company
Navient Corp plans a tax-free merger to form a new holding company, enhancing operations and shareholder value without requiring a stockholder vote.
Valor Energy closes private placement, issues new warrants
Valor Energy Inc. closes a private placement, issuing warrants to investors, potentially strengthening its financial position amid compliance challenges.
Texas Ventures Acquisition III Corp extends business combination deadline
Texas Ventures Acquisition III Corp extends its deadline for a business combination to July 2027, reflecting challenges in the blank check company sector.
Lifecore Biomedical sets date for stockholder merger vote
Lifecore Biomedical has scheduled a special meeting for stockholders to vote on a merger agreement with Lifecore Inc., impacting the pharmaceutical industry.
Conexeu Sciences reports $5 million in unregistered stock sales
Conexeu Sciences Inc. announces nearly $5 million in unregistered stock sales to enhance working capital and support corporate initiatives.
Sagimet Biosciences updates investors on clinical progress
Sagimet Biosciences provides an investor update on clinical developments and financial health, focusing on key drug candidates targeting acne and metabolic diseases.
Newbury Street II Acquisition Corp Enters Merger Agreement
Newbury Street II Acquisition Corp announces merger with Fort Robotics, marking a pivotal moment in its growth strategy within the electrical industrial apparatus sector.
Unusual Machines secures $16.9M order from Powerus Corporation
Unusual Machines, Inc. announces a $16.9 million purchase order from Powerus for drone components, enhancing its position in the growing market.